<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> stem cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>) drive <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and are suggested to initiate distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Moreover, colon <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> are reportedly more resistant to conventional chemotherapy, which is in part due to upregulation of anti-apoptotic Bcl-2 family members </plain></SENT>
<SENT sid="2" pm="."><plain>To determine whether we could circumvent this apoptotic blockade, we made use of an inducible active caspase-9 (iCasp9) construct to target <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Dimerization of iCasp9 with AP20187 in HCT116 <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells resulted in massive and rapid induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast to fluorouracil (5-FU)-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, iCasp9-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was independent of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> pathway as evidenced by Bax/Bak double deficient HCT116 cells </plain></SENT>
<SENT sid="5" pm="."><plain>Dimerizer treatment of colon <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> transduced with iCasp9 (<z:chebi fb="11" ids="17437,53115">CSC</z:chebi>-iCasp9) also rapidly induced high levels of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, while these cells were unresponsive to 5-FU in vitro </plain></SENT>
<SENT sid="6" pm="."><plain>More importantly, injection of the dimerizer into mice that developed a colon <z:chebi fb="11" ids="17437,53115">CSC</z:chebi>-iCasp9-induced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> resulted in a strong decrease in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, an increase in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and a clear loss of CD133(+) <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together, our data indicate that dimerization of iCasp9 circumvents the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> block in <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>, which results in effective <z:mp ids='MP_0010537'>tumor regression</z:mp> in vivo </plain></SENT>
</text></document>